(GPN) Global Payments - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US37940X1028
Stock:
Total Rating 27
Risk 81
Buy Signal 0.27
| Risk 5d forecast | |
|---|---|
| Volatility | 34.8% |
| Relative Tail Risk | -10.9% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.43 |
| Alpha | -43.42 |
| Character TTM | |
|---|---|
| Beta | 1.168 |
| Beta Downside | 1.206 |
| Drawdowns 3y | |
|---|---|
| Max DD | 50.88% |
| CAGR/Max DD | -0.20 |
EPS (Earnings per Share)
Revenue
Description: GPN Global Payments
Global Payments Inc. provides payment technology and software solutions for card, check, and digital-based payments in the Americas, Europe, and the Asia-Pacific. It operates through two segments, Merchant Solutions and Issuer Solutions. The Merchant Solutions segment offers authorization, settlement and funding, customer support, chargeback resolution, reconciliation and dispute management, terminal rental, sales and deployment, payment security, and consolidated billing and reporting services. This segment also provides an array of enterprise software solutions that streamline business operations of its customers in various vertical markets; and value-added solutions and services, such as point-of-sale software, analytics and customer engagement, payroll and reporting, and human capital management. The Issuer Solutions segment offers solutions that enable financial institutions and retailers to manage their card portfolios through a platform; and commercial payments, accounts payables, and electronic payment alternatives solutions for businesses and governments. It markets its products and services through direct sales force, trade associations, agent and enterprise software providers, referral arrangements with value-added resellers, and independent sales organizations. The company was founded in 1967 and is headquartered in Atlanta, Georgia.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 1.40b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -2.27 > 1.0 |
| NWC/Revenue: 62.20% < 20% (prev -2.43%; Δ 64.62% < -1%) |
| CFO/TA 0.05 > 3% & CFO 2.66b > Net Income 1.40b |
| Net Debt (13.47b) to EBITDA (3.19b): 4.23 < 3 |
| Current Ratio: 1.69 > 1.5 & < 3 |
| Outstanding Shares: last quarter (240.2m) vs 12m ago -4.60% < -2% |
| Gross Margin: 69.37% > 18% (prev 0.68%; Δ 6869 % > 0.5%) |
| Asset Turnover: 16.51% > 50% (prev 18.99%; Δ -2.48% > 0%) |
| Interest Coverage Ratio: 2.79 > 6 (EBITDA TTM 3.19b / Interest Expense TTM 630.9m) |
Altman Z'' 1.44
| A: 0.10 (Total Current Assets 12.60b - Total Current Liabilities 7.46b) / Total Assets 53.34b |
| B: 0.11 (Retained Earnings 5.94b / Total Assets 53.34b) |
| C: 0.04 (EBIT TTM 1.76b / Avg Total Assets 50.11b) |
| D: 0.20 (Book Value of Equity 5.81b / Total Liabilities 29.56b) |
| Altman-Z'' Score: 1.44 = BB |
Beneish M -3.37
| DSRI: 0.78 (Receivables 784.2m/1.08b, Revenue 8.27b/8.90b) |
| GMI: 0.97 (GM 69.37% / 67.61%) |
| AQI: 0.89 (AQ_t 0.74 / AQ_t-1 0.82) |
| SGI: 0.93 (Revenue 8.27b / 8.90b) |
| TATA: -0.02 (NI 1.40b - CFO 2.66b) / TA 53.34b) |
| Beneish M-Score: -3.37 (Cap -4..+1) = AA |
What is the price of GPN shares?
As of February 27, 2026, the stock is trading at USD 77.85 with a total of 4,262,548 shares traded.
Over the past week, the price has changed by -2.99%, over one month by +3.19%, over three months by +4.16% and over the past year by -22.40%.
Over the past week, the price has changed by -2.99%, over one month by +3.19%, over three months by +4.16% and over the past year by -22.40%.
Is GPN a buy, sell or hold?
Global Payments has received a consensus analysts rating of 3.59.
Therefor, it is recommend to hold GPN.
- StrongBuy: 11
- Buy: 1
- Hold: 20
- Sell: 1
- StrongSell: 1
What are the forecasts/targets for the GPN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 101.9 | 30.8% |
| Analysts Target Price | 101.9 | 30.8% |
GPN Fundamental Data Overview February 23, 2026
P/E Trailing = 12.5144
P/E Forward = 6.3371
P/S = 2.9967
P/B = 1.0187
P/EG = 0.5813
Revenue TTM = 8.27b USD
EBIT TTM = 1.76b USD
EBITDA TTM = 3.19b USD
Long Term Debt = 19.54b USD (from longTermDebt, last quarter)
Short Term Debt = 2.27b USD (from shortTermDebt, last quarter)
Debt = 21.81b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 13.47b USD (from netDebt column, last quarter)
Enterprise Value = 36.56b USD (23.09b + Debt 21.81b - CCE 8.34b)
Interest Coverage Ratio = 2.79 (Ebit TTM 1.76b / Interest Expense TTM 630.9m)
EV/FCF = 17.93x (Enterprise Value 36.56b / FCF TTM 2.04b)
FCF Yield = 5.58% (FCF TTM 2.04b / Enterprise Value 36.56b)
FCF Margin = 24.64% (FCF TTM 2.04b / Revenue TTM 8.27b)
Net Margin = 16.92% (Net Income TTM 1.40b / Revenue TTM 8.27b)
Gross Margin = 69.37% ((Revenue TTM 8.27b - Cost of Revenue TTM 2.53b) / Revenue TTM)
Gross Margin QoQ = 70.62% (prev 72.27%)
Tobins Q-Ratio = 0.69 (Enterprise Value 36.56b / Total Assets 53.34b)
Interest Expense / Debt = 0.94% (Interest Expense 204.5m / Debt 21.81b)
Taxrate = 18.23% (251.6m / 1.38b)
NOPAT = 1.44b (EBIT 1.76b * (1 - 18.23%))
Current Ratio = 1.69 (Total Current Assets 12.60b / Total Current Liabilities 7.46b)
Debt / Equity = 0.95 (Debt 21.81b / totalStockholderEquity, last quarter 22.89b)
Debt / EBITDA = 4.23 (Net Debt 13.47b / EBITDA 3.19b)
Debt / FCF = 6.61 (Net Debt 13.47b / FCF TTM 2.04b)
Total Stockholder Equity = 22.60b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.79% (Net Income 1.40b / Total Assets 53.34b)
RoE = 6.20% (Net Income TTM 1.40b / Total Stockholder Equity 22.60b)
RoCE = 4.18% (EBIT 1.76b / Capital Employed (Equity 22.60b + L.T.Debt 19.54b))
RoIC = 3.68% (NOPAT 1.44b / Invested Capital 39.09b)
WACC = 5.63% (E(23.09b)/V(44.90b) * Re(10.22%) + D(21.81b)/V(44.90b) * Rd(0.94%) * (1-Tc(0.18)))
Discount Rate = 10.22% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.09%
[DCF] Terminal Value 86.20% ; FCFF base≈2.37b ; Y1≈2.33b ; Y5≈2.41b
[DCF] Fair Price = 208.6 (EV 71.87b - Net Debt 13.47b = Equity 58.40b / Shares 280.0m; r=5.90% [WACC]; 5y FCF grow -2.18% → 2.90% )
EPS Correlation: 90.59 | EPS CAGR: 12.13% | SUE: 0.77 | # QB: 0
Revenue Correlation: -41.95 | Revenue CAGR: -3.36% | SUE: -2.76 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.96 | Chg7d=-0.018 | Chg30d=-0.016 | Revisions Net=-4 | Analysts=20
EPS current Year (2026-12-31): EPS=13.83 | Chg7d=+0.227 | Chg30d=+0.296 | Revisions Net=+0 | Growth EPS=+13.1% | Growth Revenue=+34.6%
EPS next Year (2027-12-31): EPS=16.27 | Chg7d=-0.437 | Chg30d=-0.584 | Revisions Net=+0 | Growth EPS=+17.7% | Growth Revenue=+6.1%
[Analyst] Revisions Ratio: -1.00 (0 Up / 4 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 2.2% (Discount Rate 10.2% - Earnings Yield 8.0%)
[Growth] Growth Spread = +29.8% (Analyst 32.0% - Implied 2.2%)
P/E Forward = 6.3371
P/S = 2.9967
P/B = 1.0187
P/EG = 0.5813
Revenue TTM = 8.27b USD
EBIT TTM = 1.76b USD
EBITDA TTM = 3.19b USD
Long Term Debt = 19.54b USD (from longTermDebt, last quarter)
Short Term Debt = 2.27b USD (from shortTermDebt, last quarter)
Debt = 21.81b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 13.47b USD (from netDebt column, last quarter)
Enterprise Value = 36.56b USD (23.09b + Debt 21.81b - CCE 8.34b)
Interest Coverage Ratio = 2.79 (Ebit TTM 1.76b / Interest Expense TTM 630.9m)
EV/FCF = 17.93x (Enterprise Value 36.56b / FCF TTM 2.04b)
FCF Yield = 5.58% (FCF TTM 2.04b / Enterprise Value 36.56b)
FCF Margin = 24.64% (FCF TTM 2.04b / Revenue TTM 8.27b)
Net Margin = 16.92% (Net Income TTM 1.40b / Revenue TTM 8.27b)
Gross Margin = 69.37% ((Revenue TTM 8.27b - Cost of Revenue TTM 2.53b) / Revenue TTM)
Gross Margin QoQ = 70.62% (prev 72.27%)
Tobins Q-Ratio = 0.69 (Enterprise Value 36.56b / Total Assets 53.34b)
Interest Expense / Debt = 0.94% (Interest Expense 204.5m / Debt 21.81b)
Taxrate = 18.23% (251.6m / 1.38b)
NOPAT = 1.44b (EBIT 1.76b * (1 - 18.23%))
Current Ratio = 1.69 (Total Current Assets 12.60b / Total Current Liabilities 7.46b)
Debt / Equity = 0.95 (Debt 21.81b / totalStockholderEquity, last quarter 22.89b)
Debt / EBITDA = 4.23 (Net Debt 13.47b / EBITDA 3.19b)
Debt / FCF = 6.61 (Net Debt 13.47b / FCF TTM 2.04b)
Total Stockholder Equity = 22.60b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.79% (Net Income 1.40b / Total Assets 53.34b)
RoE = 6.20% (Net Income TTM 1.40b / Total Stockholder Equity 22.60b)
RoCE = 4.18% (EBIT 1.76b / Capital Employed (Equity 22.60b + L.T.Debt 19.54b))
RoIC = 3.68% (NOPAT 1.44b / Invested Capital 39.09b)
WACC = 5.63% (E(23.09b)/V(44.90b) * Re(10.22%) + D(21.81b)/V(44.90b) * Rd(0.94%) * (1-Tc(0.18)))
Discount Rate = 10.22% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.09%
[DCF] Terminal Value 86.20% ; FCFF base≈2.37b ; Y1≈2.33b ; Y5≈2.41b
[DCF] Fair Price = 208.6 (EV 71.87b - Net Debt 13.47b = Equity 58.40b / Shares 280.0m; r=5.90% [WACC]; 5y FCF grow -2.18% → 2.90% )
EPS Correlation: 90.59 | EPS CAGR: 12.13% | SUE: 0.77 | # QB: 0
Revenue Correlation: -41.95 | Revenue CAGR: -3.36% | SUE: -2.76 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.96 | Chg7d=-0.018 | Chg30d=-0.016 | Revisions Net=-4 | Analysts=20
EPS current Year (2026-12-31): EPS=13.83 | Chg7d=+0.227 | Chg30d=+0.296 | Revisions Net=+0 | Growth EPS=+13.1% | Growth Revenue=+34.6%
EPS next Year (2027-12-31): EPS=16.27 | Chg7d=-0.437 | Chg30d=-0.584 | Revisions Net=+0 | Growth EPS=+17.7% | Growth Revenue=+6.1%
[Analyst] Revisions Ratio: -1.00 (0 Up / 4 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 2.2% (Discount Rate 10.2% - Earnings Yield 8.0%)
[Growth] Growth Spread = +29.8% (Analyst 32.0% - Implied 2.2%)